Diana Ernst, RPh

Most Recent Articles by Diana Ernst, RPh

Mortality Risk Compared Among Men Receiving Drug Therapy for BPH/LUTS

Mortality Risk Compared Among Men Receiving Drug Therapy for BPH/LUTS

By

Researchers conducted a retrospective matched cohort study to compare the risk of death among BPH patients treated with 5ARIs, as monotherapy or in combination with alpha-blockers, and those treated with alpha-blockers alone.

FDA approves Heplisav-B vaccine for hepatitis B treatment

FDA approves Heplisav-B vaccine for hepatitis B treatment

By

The Food and Drug Administration (FDA) has approved Heplisav-B for the prevention of infection caused by all known subtypes of hepatitis B virus.

CDC releases updated influenza vaccine recommendations for 2017-2018

CDC releases updated influenza vaccine recommendations for 2017-2018

By

The Advisory Committee on Immunization Practices has released the guidelines for the 2017-2018 season.

FDA approves label changes for two HIV drugs

FDA approves label changes for two HIV drugs

By

The FDA Drug Interactions section has been updated to include revised information on concomitant use of corticosteroids with these drugs.

Proton pump inhibitor use may decrease healthcare visits in GERD patients

Proton pump inhibitor use may decrease healthcare visits in GERD patients

By

Among GERD patients, the mean annual ARI episode dropped from 4.39 during the year before PPI treatment to 3.89 after treatment with a PPI.

More Articles by Diana Ernst, RPh

Sign Up for Free e-newsletters